Picture of Aspen Aerogels logo

ASPN — Aspen Aerogels News Story

0.000.00%
us flag iconLast trade - 00:00
Basic MaterialsSpeculativeSmall CapNeutral

Aspen Aerogels Inc reports results for the quarter ended in December - Earnings Summary

* Aspen Aerogels Inc  ASPN.N  reported a quarterly adjusted
loss
of 1 cent​​ per share for the quarter ended in December, higher
than the same quarter last year, when the company reported EPS
of -20 cents.  The mean expectation of nine analysts for the
quarter was for a loss of 12 cents per share. Wall Street
expected results to range from -13 cents to -10 cents per share.
    * Revenue rose 41.3% to $84.22 million from a year ago;
analysts
expected $80.86 million. 
    * Aspen Aerogels Inc shares had fallen by 24.0% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 32.8%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the specialty
chemicals
peer group is also "buy"

Wall Street's median 12-month price target for Aspen Aerogels
Inc is $20.00 
This summary was machine generated from LSEG data February 12 at
10:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.12          -0.01          Beat
 Sep. 30 2023      -0.27          -0.19          Beat
 Jun. 30 2023      -0.36          -0.22          Beat
 Mar. 31 2023      -0.40          -0.24          Beat

Recent news on Aspen Aerogels

See all news